You may qualify and be compensated up to $5,600 for participating in this study if you meet the following criteria:
- Males and females over 65 years old
- Non-smokers and smokers
- Weight over 110.3 pounds
- BMI between 19 and 32 (use the BMI calculator below)
Next check-in dates: 25 April 2023 (a date in May will be confirmed soon). Click here for the study calendars
Refer a friend: earn up to $500 when your friend participates in this study.
For more information, contact our recruiters at 844 BIO 8459 or email us at email@example.com
Study objective: testing an investigational drug for treating agitation associated with dementia and comparing it with an anti-psychotic drug widely prescribed to treat agitation, depression, and anxiety in elderly patients.
What is dementia? Dementia is a general term for memory loss, language, problem-solving, and other thinking abilities severe enough to interfere with daily life. Alzheimer’s disease is the most common cause of progressive dementia in older adults, but there are several other causes of dementia. 10% of U.S. adults ages 65 and older have dementia.